Author

Sahil Loomba

Harvard UniversityORCID 0000-0002-5043-9746Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:CRISPR screen· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1 Research Focus:protein folding & dynamics· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Dinis· 1 shared Alexander TongiD· 1 shared Anish VasaniD· 1 shared Ariane MoraiD· 1 shared Béla P. FrohniD· 1 shared Donald E. IngberiD· 1 shared E. Gardner· 1 shared Frédéric VigneaultiD· 1 shared

Activity by Year

2022-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperNeuroscience

A. Dinis

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BiochemistrybioRxivPreprintSep 11, 2026

Reframing enzyme function prediction as conditional generation

William JF Rieger, Sebastian Haeussermann, Luca Herrmann…·Ariane Mora

Fluxion generates enzyme function predictions by modeling electron flow trajectories, enabling function generation beyond static classification.

DOI 10.64898/2026.09.09.750355

proteomicsdeep learning

𝕏 PostBluesky

NeurosciencebioRxivPreprintMar 20, 2022

Target-agnostic discovery of Rett Syndrome therapeutics by coupling computational network analysis and CRISPR-enabled in vivo disease modeling

R. Novak, Tiffany Lin, S. Kaushal…·Donald E. Ingber

This paper identifies vorinostat as a potential repurposed therapy for Rett syndrome by combining computational network analysis with CRISPR-edited Xenopus models, showing efficacy across multiple organ systems.

17 citations

𝕏 PostBluesky